← Back to headlines
UBS and Bernstein Upgrade Pharma and Telecom Stocks
UBS has upgraded Jazz Pharmaceuticals to a "Buy" rating with a new $307 price target, signaling a potential turning point for the company. Separately, Bernstein lifted American Tower to "Outperform" with a $207 price target, suggesting it's a good time to invest in tower REITs.
19 May, 16:24 — 19 May, 16:24
Sources
Showing 1 of 1 sources
Related Stories
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
1h ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
4h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
5h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
5h ago